GNLX
Price
$3.11
Change
+$0.21 (+7.24%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
109.05M
14 days until earnings call
VSTM
Price
$7.33
Change
+$0.21 (+2.95%)
Updated
Apr 24, 02:54 PM (EDT)
Capitalization
362.49M
Ad is loading...

GNLX vs VSTM

Header iconGNLX vs VSTM Comparison
Open Charts GNLX vs VSTMBanner chart's image
Genelux
Price$3.11
Change+$0.21 (+7.24%)
Volume$3.76K
Capitalization109.05M
Verastem
Price$7.33
Change+$0.21 (+2.95%)
Volume$301
Capitalization362.49M
GNLX vs VSTM Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. VSTM commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and VSTM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (GNLX: $2.90 vs. VSTM: $7.12)
Brand notoriety: GNLX and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 98% vs. VSTM: 128%
Market capitalization -- GNLX: $109.05M vs. VSTM: $362.49M
GNLX [@Biotechnology] is valued at $109.05M. VSTM’s [@Biotechnology] market capitalization is $362.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 4 TA indicator(s) are bullish while VSTM’s TA Score has 4 bullish TA indicator(s).

  • GNLX’s TA Score: 4 bullish, 5 bearish.
  • VSTM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than VSTM.

Price Growth

GNLX (@Biotechnology) experienced а +12.84% price change this week, while VSTM (@Biotechnology) price change was +43.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

GNLX is expected to report earnings on May 08, 2025.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($362M) has a higher market cap than GNLX($109M). VSTM YTD gains are higher at: 37.718 vs. GNLX (22.881). GNLX has higher annual earnings (EBITDA): -26.78M vs. VSTM (-88.92M). VSTM has more cash in the bank: 113M vs. GNLX (34.1M). GNLX has less debt than VSTM: GNLX (2.04M) vs VSTM (41.4M). VSTM has higher revenues than GNLX: VSTM (10M) vs GNLX (8K).
GNLXVSTMGNLX / VSTM
Capitalization109M362M30%
EBITDA-26.78M-88.92M30%
Gain YTD22.88137.71861%
P/E RatioN/AN/A-
Revenue8K10M0%
Total Cash34.1M113M30%
Total Debt2.04M41.4M5%
FUNDAMENTALS RATINGS
VSTM: Fundamental Ratings
VSTM
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNLXVSTM
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BVSIX16.170.16
+1.00%
Baywood Socially Responsible Instl
ACFOX57.17N/A
N/A
American Century Focused Dynamic Gr Inv
ITCTX26.66N/A
N/A
VY® T. Rowe Price Capital Apprec S2
BMIAX6.52N/A
N/A
BNY Mellon Income Stock A
IEGYX20.33N/A
N/A
Invesco EQV Intl Small Company Y

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-1.36%
VSTM - GNLX
47%
Loosely correlated
+1.14%
SNSE - GNLX
33%
Poorly correlated
+6.90%
HOOK - GNLX
31%
Poorly correlated
+4.00%
ANIX - GNLX
30%
Poorly correlated
+0.37%
SPRB - GNLX
27%
Poorly correlated
+2.39%
More

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with GNLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then GNLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
+1.14%
GNLX - VSTM
47%
Loosely correlated
-1.36%
ZLDAF - VSTM
47%
Loosely correlated
N/A
SNSE - VSTM
45%
Loosely correlated
+6.90%
HOOK - VSTM
39%
Loosely correlated
+4.00%
TGTX - VSTM
38%
Loosely correlated
+3.95%
More